Literature DB >> 16094700

Altered profiles of nuclear matrix proteins during the differentiation of human gastric mucous adenocarcinoma MGc80-3 cells.

Chun-Hong Zhao1, Qi-Fu Li.   

Abstract

AIM: To find and identify specific nuclear matrix proteins associated with proliferation and differentiation of carcinoma cells, which will be potential markers for cancer diagnosis and targets in cancer therapy.
METHODS: Nuclear matrix proteins were selectively extracted from MGc80-3 cells treated with or without hexamethylamine bisacetamide (HMBA), and subjected to 2-D gel electrophoresis. The resulted protein patterns were analyzed by Melanie software. Spots of nuclear matrix proteins differentially expressed were excised and subjected to in situ digestion with trypsin. Peptide masses were obtained by matrix-assisted laser-desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) analysis and submitted for database searching using Mascot tool.
RESULTS: The MGc80-3 cells were induced into differentiation by HMBA. There were 22 protein spots which changed remarkably in the nuclear matrix, from differentiation of MGc80-3 cells compared to control. Eleven of which were identified. Seven proteins--actin, prohibitin, porin 31HL, heterogeneous nuclear ribonucleoprotein A2/B1, vimentin, ATP synthase, and heat shock protein 60 were downregulated, whereas three proteins--heat shock protein gp96, heat shock protein 90-beta, and valosin-containing protein were upregulated, and the oxygen-regulated protein was only found in the differentiated MGc80-3 cells.
CONCLUSION: The induced differentiation of carcinoma cells is accompanied by the changes of nuclear matrix proteins. Further characterization of those proteins will show the mechanism of cellular proliferation and differentiation, as well as cancer differentiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094700      PMCID: PMC4615401          DOI: 10.3748/wjg.v11.i30.4628

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  Molecular structure and physiological function of chloride channels.

Authors:  Thomas J Jentsch; Valentin Stein; Frank Weinreich; Anselm A Zdebik
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

2.  Expression of heat shock protein 90 beta in human gastric cancer tissue and SGC7901/VCR of MDR-type gastric cancer cell line.

Authors:  X Liu; L Ye; J Wang; D Fan
Journal:  Chin Med J (Engl)       Date:  1999-12       Impact factor: 2.628

Review 3.  The nuclear matrix: a structural milieu for genomic function.

Authors:  R Berezney; M J Mortillaro; H Ma; X Wei; J Samarabandu
Journal:  Int Rev Cytol       Date:  1995

4.  Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix.

Authors:  M D Gooden; R B Vernon; J A Bassuk; E H Sage
Journal:  J Cell Biochem       Date:  1999-08-01       Impact factor: 4.429

5.  Nuclear matrix proteins in normal and breast cancer cells.

Authors:  P S Khanuja; J E Lehr; H D Soule; S K Gehani; A C Noto; S Choudhury; R Chen; K J Pienta
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

6.  Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling.

Authors:  Gina Fusaro; Piyali Dasgupta; Shipra Rastogi; Bharat Joshi; Srikumar Chellappan
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

7.  60KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis.

Authors:  F Cappello; M Bellafiore; A Palma; S David; V Marcianò; T Bartolotta; C Sciumè; G Modica; F Farina; G Zummo; F Bucchieri
Journal:  Eur J Histochem       Date:  2003       Impact factor: 3.188

8.  Nuclear matrix proteins in human colon cancer.

Authors:  S K Keesee; M D Meneghini; R P Szaro; Y J Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

9.  Bladder cancer-associated nuclear matrix proteins.

Authors:  R H Getzenberg; B R Konety; T A Oeler; M M Quigley; A Hakam; M J Becich; R R Bahnson
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

Review 10.  Heat shock protein gp96 and cancer immunotherapy.

Authors:  Yue Peibin; Yang Shude; Huang Changzhi
Journal:  Chin Med Sci J       Date:  2002-12
View more
  6 in total

1.  Aberrant expression of nuclear matrix proteins during HMBA-induced differentiation of gastric cancer cells.

Authors:  Guang-Jun Jing; Dong-Hui Xu; Song-Lin Shi; Qi-Fu Li; San-Ying Wang; Fu-Yun Wu; Hai-Yan Kong
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.

Authors:  Zhao Zhang; Yanyan Wang; Chuanchuan Li; Zhubing Shi; Qian Hao; Wenjia Wang; Xiaomin Song; Yun Zhao; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-06-25       Impact factor: 5.157

3.  Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.

Authors:  Qi-Fu Li; Ying Liang; Song-Lin Shi; Qing-Rong Liu; Dong-Hui Xu; Guang-Jun Jing; San-Ying Wang; Hai-Yan Kong
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

4.  Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells.

Authors:  Dong-Hui Xu; Jian Tang; Qi-Fu Li; Song-Lin Shi; Xiang-Feng Chen; Ying Liang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Vimentin binds to G-quadruplex repeats found at telomeres and gene promoters.

Authors:  Silvia Ceschi; Michele Berselli; Marta Cozzaglio; Mery Giantin; Stefano Toppo; Barbara Spolaore; Claudia Sissi
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

6.  β-catenin induces expression of prohibitin gene in acute leukemic cells.

Authors:  Dong Min Kim; Hanbit Jang; Myung Geun Shin; Jeong-Hoon Kim; Sang Mo Shin; Sang-Hyun Min; Il-Chul Kim
Journal:  Oncol Rep       Date:  2017-04-25       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.